About Liquidia Corporation
Liquidia is a small-cap biopharma focused on pulmonary arterial hypertension treatments. No dividend, binary FDA and pipeline risk. Options liquidity is limited and spreads can be wide. Generally not practical for consistent CSP strategies due to thin markets and event-driven price action.
Drug Manufacturers - Specialty & Generic